Drug intelligence / Profile preview

Dialypro

Development stage
Unknown
Lead developer
PharmaDiall
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Recombinant Proteins and Enzymes, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Administration
Oral
01

Overview

Dialypro is an oral dietary supplement developed by H.A.C. Pharma, specifically classified as a "dietary food for special medical purposes" (FSMP) for the dietary management of patients undergoing dialysis. It is a protein-energy powder enriched with high-nutritional-value proteins and calories to compensate for insufficient oral intake and protein loss common in renal failure. The formulation is specifically designed to be low in electrolytes (sodium, potassium), phosphorus, and vitamin A to adhere to the strict dietary restrictions required for dialysis patients. It contains essential micronutrients including vitamins C and E (antioxidants), trace elements (iron, zinc, selenium), calcium, and L-carnitine. Dialypro is flavorless and soluble, intended for use under medical supervision as a supplement to a standard diet rather than an exclusive source of nutrition.

Brand names
Dialypro

Beyond the preview

Go deeper on Dialypro.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dialypro.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call